-
A–D′
Overexpression of
mCherry
RNAi
,
InR
CA
; mCherry
RNAi
,
Sog
RNAi
; mCherry
RNAi
and Sog
RNAi
;InR
CA
under the control of
r4‐GAL4 stained for pMad and DAPI. The same
mCherry
RNAi
sample was used in Fig
7M, as these experiments were carried out together).
-
E
Quantification of pMad levels of (A–D′).
mCherry
RNAi
(
n = 17),
InR
CA
; mCherry
RNAi
(
n = 7),
Sog
RNAi
; mCherry
RNAi
(
n = 26),
and Sog
RNAi
;InR
CA
(
n = 19), The same
mCherry
RNAi
and
InR
CA
;
mCherry
RNAi
data points were used as in Fig
6Q.
-
F, G
Muscle fillets stained with phalloidin (Actin) from tumour‐bearing (QRas
V12
scrib
RNAi
) animals where mCherry
RNAi
or sog was expressed in the fat body using r4‐GAL4.
-
H
Quantification of muscle detachment in (F, G). w
1118
(n = 3), mCherry
RNAi
(n = 10), sog (n = 8).
-
I, J
Muscle fillets stained with phalloidin (Actin) from upon tumour‐specific overexpression of mCherry
RNAi
or Sog in Ras
V12
dlg1
RNAi
tumour‐bearing animals.
-
K
Quantification of muscle detachment in (I, J). w
1118
(n = 3), mCherry
RNAi
(n = 4), sog (n = 6).
-
L, M
Muscle fillets stained with phalloidin (Actin) from tumour‐bearing animals with overexpression of luciferase or sog in the muscle via MEF2‐GAL4.
-
N
Quantification of muscle detachment in (L, M). w
1118
(n = 3), luciferase (n = 10), Sog (n = 16).
-
O, P
Fat body stained with the ECM protein Nidogen from QRas
V12
scrib
RNAi
tumour‐bearing animals, where mCherry
RNAi
or UAS‐sog was expressed in the fat body (r4‐GAL4).
-
Q
Quantification of normalised fat body Nidogen staining in (O, P). mCherry
RNAi
(n = 9), UAS‐sog (n = 10). Scale bar is 50 μm for fat body.
-
R
Sog levels in the haemolymph of w
1118
, Ras
V12
dlg1
RNAi
and UAS‐TIMP; Ras
V12
dlg1
RNAi
tumour‐bearing animals (n = 4,4,3).